Aleniglipron Phase 2 Body Composition Study
Clinical trial NCT07169942 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07169942
- Sponsor
- Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-15
- Primary completion
- 2026-08-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.